Synergistic inhibition of Lactobacillus acidophilus and Clostridium butyricum against Shigella flexneri in vitro

WANG Yizhou; FANG Kai; WANG Hui; DOU Jie; ZHOU Changlin

doi:10.11665/j.issn.1000-5048.20150118

Journal of China Pharmaceutical University > 2015 > 46(1): 117-122. > DOI: 10.11665/j.issn.1000-5048.20150118

WANG Yizhou, FANG Kai, WANG Hui, DOU Jie, ZHOU Changlin. Synergistic inhibition of Lactobacillus acidophilus and Clostridium butyricum against Shigella flexneri in vitro[J]. Journal of China Pharmaceutical University, 2015, 46(1): 117-122. DOI: 10.11665/j.issn.1000-5048.20150118

Citation:

PDF (1093 KB)

Synergistic inhibition of Lactobacillus acidophilus and Clostridium butyricum against Shigella flexneri in vitro

More Information

Graphical Abstract

Abstract

Abstract

An agar diffusion method was used to investigate the antimicrobial activities of fermentation broth of Lactobacillus acidophilus(L. acidophilus), and Clostridium butyricum(C. butyricum)against Shigella flexneri(S. flexneri)infection in vitro. It was found that cell-free culture supernatants(CFCSs)of L. acidophilus and C. butyricum possessed remarkable synergistic anti-S. flexneri activity in vitro and the antimicrobial activity of the mixed culture was 17. 2% and 22. 4% greater, than single strains alone, respectively. Meanwhile, there was a symbiotic relationship between L. acidophilus and C. butyricum. The result showed that the biomass accumulation of the mixed culture reached 4. 27 g/L(DCW)and increased by 6. 0% and 30. 6% compared to the L. acidophilus and C. butyricum, respectively. Moreover, L. acidophilus and C. butyricum clearly inhibited S. flexneri adhesion to Caco-2 cells by 75. 8% and 81. 2%, and the combination of these two probiotic strains demonstrated the highest inhibition rate, reaching 84. 2%, while the viability of Caco-2 cells treated with L. acidophilus, C. butyricum or their combination was increased by 11. 5%, 12. 5% and 22. 9%, respectively. The synergistic effect of L. acidophilus and C. butyricum provided better protection against Shigella flexneri infection, which represents a promising alternative therapy for shigellosis.
- Lactobacillus acidophilus,
- Clostridium butyricum,
- synergistic antimicrobial activity,
- Shigella flexneri,
- probiotics,
- adherence inhibition

FullText(HTML)

References (20)

References

[1]	Boirivant M,Strober W.The mechanism of action of probiotics[J].Curr Opin Gastroenterol,2007, 23(6):679-692.
[2]	Jeon SG,Kayama H,Ueda Y, et al.Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon[J].PLoS Pathog,2012, 8(5):e1002714.
[3]	Tejero-Sariñena S,Barlow J,Costabile A, et al.In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens:Evidence for the effects of organic acids[J].Anaerobe,2012, 18(5):530-538.
[4]	Gao Q,Qi L,Wu T, et al.An important role of interleukin-10 in counteracting excessive immune response in HT-29 cells exposed to Clostridium butyricum[J].BMC Microbiol,2012, 12:100.
[5]	Cristiano P,Rubina S,Giorgos B, et al.Probiotics promote gut health through stimulation of epithelial innate immunity[J].PNAS,2010, 107(1):454-459.
[6]	Kwon HK,Lee CG,So JS, et al.Generation of regulatory dendritic cells and CD4⁺ Foxp3⁺ T cells by probiotics administration suppresses immune disorders[J].PNAS,2010, 107(5):2159-2164.
[7]	Moorthy G,Murali MR,Devaraj SN.Lactobacilli facilitate maintenance of intestinal membrane integrity during Shigella dysenteriae 1 infection in rats[J].Nutrition,2005, 25(3):350-358.
[8]	Shim DH,Suzuki T,Chang SY, et al.New animal model of shigellosis in the guinea pig:its usefulness for protective efficacy studies[J].J Immunol,2007, 178(4):2476-2482.
[9]	Njuguna HN,Cosmas L,Williamson J, et al.Use of population-based surveillance to define the high incidence of Shigellosis in an urban slumin nairobi,Kenya[J].PLoS One,2013, 8(3):e58437.
[10]	Wu L,Wang G,Gao F.Study on the mechanism of anti-Shigella flexneri infection by Bifidobacteria[J].J Dali Univ(大理学院学报),2010, 9(6):16-18.
[11]	Ram PK,Crump JA,Gupta SK, et al.Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries,1984-2005[J].Epidemiol Infect,2008, 136(5):577-603.
[12]	Chang Z,Lu S,Chen L, et al.Causative species and serotypes of shigellosis in mainland China:systematic review and meta-analysis[J].PLoS One,2012, 7(12):e52515.
[13]	Mandal J,V G,Emelda J, et al.The recent trends of shigellosis:a JIPMER perspective[J].J Clin Diagn Res,2012, 6(9):1474-1477.
[14]	Johnston BC,Ma SS,Goldenberg JZ, et al.Probiotics for the prevention of Clostridium difficile-associated diarrhea:a systematic review and meta-analysis[J].Ann Intern Med,2012, 157(12):878-888.
[15]	Huang J,Han M,Yu X.Characteristics and culture conditions of a forage Clostridium butyricum(一株饲用酪酸菌特性及培养条件的研究)[J].Feed Ind(饲料工业),2004, 25(2):22-25.
[16]	Zhang Y,Zhang L,Du M, et al.Antimicrobial activity against Shigella sonnei and probiotic properties of wild Lactobacilli from fermented food[J].Microbiol Res,2011, 167(1):27-31.
[17]	Parsot C, Sansonetti PJ. Invasion and pathogenesis of Shigella infections[J].Curr Top Microbiol Immunol,1996, 209:25-42.
[18]	Zhang CY.Screening and reaction mechanism of probiotic bacteria inhibition of Shigella sonnei(抑制宋内志贺益生菌株的筛选及作用机制研究)[D].Heilongjiang:Harbin Institute of Technology,2011.
[19]	Chen XN.Study on the interaction between Bifidobactrium longum NCC2705 and human intestinal epithelial cell line Caco-2(长双歧杆菌NCC2705与宿主细胞Caco-2相互作用的研究)[D].Jilin:Jilin University,2010.
[20]	Porter CK,Choi D,Cash B, et al.Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness[J].BMC Gastroenterol,2013,13:46.

[1]	WU Lingxi, DU Yixuan, GAO Xiangdong. Inhibitory effect of IL-27 on the overactivation of microglia[J]. Journal of China Pharmaceutical University, 2024, 55(6): 801-808. DOI: 10.11665/j.issn.1000-5048.2024022702
[2]	CUI Tao, WU Weidang, CI Xiaoyan, LI Wei, GUO Chuanmin, XU Jing, YI Xiulin, LIU Changxiao. Evaluation of tolerance and pharmacodynamics of nano-micelle irinotecan formulation[J]. Journal of China Pharmaceutical University, 2019, 50(2): 175-179. DOI: 10.11665/j.issn.1000-5048.20190207
[3]	YUE Juanjuan, CUI Hanyue, WANG Hui, YE Bin, CHEN Dingding. Protective effects of losartan potassium on 5/6 nephrectomy-induced chronic heart failure in rats[J]. Journal of China Pharmaceutical University, 2016, 47(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20160617
[4]	JIANG Yuqiu, TANG Qiaofei, ZHANG Shuang, YAN Zhiyong. Combined effects of gallic acid and ciprofloxacin on the murine chronic rhinosinusitis model in mice[J]. Journal of China Pharmaceutical University, 2015, 46(5): 600-604. DOI: 10.11665/j.issn.1000-5048.20150514
[5]	CHEN Lu, LI Jiajie, PAN Cailong, ZHOU Danli, LIU Wentao, ZHANG Guangqin. Tetramethylpyrazine attenuates morphine tolerance through suppressing spinal microglia activation in mice[J]. Journal of China Pharmaceutical University, 2015, 46(2): 230-234. DOI: 10.11665/j.issn.1000-5048.20150216
[6]	WANG Yu, ZHAO Li, MIAO Hanchi, LI Zhiyu, GUO Qinglong. Apoptosis induction of oroxylin A in human chronic myelogenous leukemia cell line K562[J]. Journal of China Pharmaceutical University, 2014, 45(2): 232-236. DOI: 10.11665/j.issn.1000-5048.20140218
[7]	DENG Danni, TIAN Hong, YAO Wenbing. Advances in therapeutic B-cell vaccines against chronic diseases[J]. Journal of China Pharmaceutical University, 2013, 44(5): 470-475. DOI: 10.11665/j.issn.1000-5048.20130517
[8]	FENG Lan-ying, HUANG Wen-ye. Expression and regulation of Bim protein in chronic myelogenous leukemia[J]. Journal of China Pharmaceutical University, 2009, 40(6): 571-575.
[9]	Effect of Amygdalin on Chronic Gastritis and Chronic Atrophic Gastritis[J]. Journal of China Pharmaceutical University, 2002, (1): 47-49.
[10]	Study on the Tolerance of the Rabbit Body Temperature Response to Bacterial Endotoxin[J]. Journal of China Pharmaceutical University, 1999, (3): 64-66.

Cited By

Get Citation

PDF

XML

Article views (2719) PDF downloads (2608)

Turn off MathJax

Article Contents

Abstract

References

Synergistic inhibition of Lactobacillus acidophilus and Clostridium butyricum against Shigella flexneri in vitro

Abstract

References

Related Articles

Catalog

Synergistic inhibition of Lactobacillus acidophilus and Clostridium butyricum against Shigella flexneri in vitro

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content